ArticleBlood advances2023

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy.

Annette von Drygalski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.